FDA Finalizes Guidance on Microdose Radiopharmaceutical Diagnostic Drugs

International Pharmaceutical Regulatory Monitor
A A
Sponsors conducting nonclinical radiopharmaceutical diagnostic drug trials can seek waivers for specific nonclinical pharmacology or toxicology studies, according to final guidance from the FDA.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00